Sumitomo Pharma Co Ltd 2022 IR
The report outlines Sumitomo Pharma's transition to its new name and its progress under the Mid-term Business Plan 2022. Key achievements include launching TWYMEEG in Japan and RETHYMIC in the U.S., alongside establishing a strategic alliance with Otsuka Pharmaceutical for joint development of psychiatric pipelines. The company advanced its digital transformation by utilizing DrugOME and Digital Innovation platforms to enhance R&D efficiency. On the environmental front, Sumitomo Pharma committed to achieving net-zero greenhouse gas emissions by 2050 and transitioned to 100% renewable electricity at its Oita and Suzuka production plants.
Company: Sumitomo Pharma Co Ltd
Sector: Health Care
Country: Japan
Year: 2022
Type: IR
Pages: 122
Sumitomo Pharma Co Ltd
Integrated Report
The report outlines Sumitomo Pharma's transition to its new name and its progress under the Mid-term Business Plan 2022. Key achievements include launching TWYMEEG in Japan and RETHYMIC in the U.S., alongside establishing a strategic alliance with Otsuka Pharmaceutical for joint development of psychiatric pipelines. The company advanced its digital transformation by utilizing DrugOME and Digital Innovation platforms to enhance R&D efficiency. On the environmental front, Sumitomo Pharma committed to achieving net-zero greenhouse gas emissions by 2050 and transitioned to 100% renewable electricity at its Oita and Suzuka production plants.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2021
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees